TScan Therapeutics' departing CEO David Southwell and CSO/COO Gavin MacBeath
March 31, 2023 10:17 AM EDT
People

TCR up­start an­nounces CEO ex­it, with CSO now act­ing re­place­ment

Paul Schloesser

Associate Editor

A pub­lic T cell biotech’s chief ex­ec­u­tive has de­cid­ed to leave the com­pa­ny.

TScan Ther­a­peu­tics said Fri­day morn­ing that CEO David …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Blue­bird bio to sell to in­vest­ment funds af­ter strug­gling to make mon­ey from gene ther­a­pies

CBER's deputy di­rec­tor de­parts as staff shake­up con­tin­ues

Eli Lil­ly stock­piles $548M of oral weight loss drug ahead of launch

Will CRISPR mat­ter?

FDA ap­proves first drug to treat ul­tra-rare lipid stor­age dis­ease

sponsored

Trust­ed pro­tec­tion: Why the cur­rent meningo­coc­cal vac­ci­na­tion sched­ule shouldn’t change with­out strong ev­i­dence

A service from the Financial Times